Compound ID | 763
PD 149060
Class: Protein synthesis inhibitor (boxazomycin derivative)
| Spectrum of activity: | Gram-positive |
| Details of activity: | The boxazomycin antibiotics demonstrate potent activity against anaerobes and Gram positives including S. pyogenes and S. aureus |
| Description: | Song Y, Domagala JM, Turner WR, et al. Boxazomycin analogues as new antibacterial agents synthesis and structure-activity relationships. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995; 116. |
| Institute where first reported: | Parke Davis Pharmaceutical Research (Pfizer, USA) |
| Year first mentioned: | 1995 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.